Back to search
Advanced Breast Cancer (Parts 1 and 2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Breast Cancer (Parts 1 and 2) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Breast Cancer (Parts 1 and 2) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase I/II, multi-site, open-label, two-part study designed to evaluate the efficacy, safety, optimized dose and contribution of components of BNT323…
The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in par…
The purpose of this two part multicenter, randomized, double-blind, placebo-controlled, Phase III study is to evaluate the efficacy and safety of alpelisib comp…
The purpose of this study is to assess the safety and efficacy of alpelisib plus fulvestrant in men and postmenopausal women with hormone receptor (HR) positive…